This paper summarizes recent research on the importance of zinc for human health, and reviews available methods of evaluating zinc status in individuals and populations. The lack of generally accepted biomarkers of zinc status has impeded estimation of the global prevalence of zinc deficiency. Although measurement of zinc consumption and/or plasma zinc concentration can be used to assess population zinc status, few countries have collected adequate data to permit estimation of the prevalence of zinc deficiency. An alternative method, described herein, is to estimate the zinc content of national food supplies, using FAO food balance sheets; the assumed bioavailability of that zinc based on phytate:zinc molar ratios; and the relation between absorbable zinc and theoretical requirements according to country-specific demographics. The results of these analyses indicate that nearly half of the world's population is at risk for inadequate zinc intake, suggesting that public health programs are urgently needed to control zinc deficiency.
Zinc in the environment and in biology
Zinc is a bluish-white metallic element (atomic number 30, atomic weight 65.4) , which makes up about 0.02% of the earth's crust and is the twentythird most abundant element. Because of its nature as a transitional element in the periodic table, zinc possesses certain chemical properties that make it especially useful and important in biological systems. Specifically, zinc is able to constitute strong, but readily exchangeable and flexible, complexes with organic molecules, thereby enabling it to modify the three-dimensional structure of nucleic acids, specific proteins, and cellular membranes and influence the catalytic properties of many enzyme systems and intracellular signaling. Zinc is associated with more than 50 distinct metalloenzymes, which have a diverse range of functions, including the synthesis of nucleic acids and specific proteins, such as hormones and their receptors [1] . For these reasons, zinc plays a central role in cellular growth, differentiation, and metabolism. Of further interest is zinc's absence of redox properties, which allows it to be transported in biological systems without inducing oxidant damage, as can occur with other trace elements such as iron and copper.
Prasad [2] reviewed the early history of research on the biological importance of zinc. To summarize from his report, zinc was first recognized as an essential nutrient for microorganisms more than 125 years ago. Appreciation of its essentiality for higher plants, rats and mice, poultry, and swine followed during the period from the 1920s through the 1950s. Despite these observations, researchers remained skeptical about the possibility of zinc deficiency in humans because of the element's ubiquity in the environment. Nevertheless, evidence of human zinc deficiency began to emerge in the 1960s, when cases of zincresponsive dwarfism and delayed sexual maturation were first reported among Egyptian adolescents. Since then, clinical studies of children with acrodermatitis enteropathica, an inborn error of zinc metabolism resulting in poor zinc absorption and consequent severe zinc deficiency, have confirmed the critical role of zinc in physical growth and gastrointestinal and immune function [3] . Moreover, as described below, zinc intervention trials have produced positive growth responses and reduced rates of infections in high-risk children of vulnerable populations.
Zinc metabolism
Zinc is absorbed into the body through the small intestine, which also regulates whole-body homeostasis Kenneth H. Brown, Sara E. Wuehler, and Jan M. Peerson through changes in both the fractional absorption of dietary zinc and excretion of endogenous zinc in pancreatic juice and other gastrointestinal secretions [4, 5] . Some zinc is also lost from the body through urine, menstrual flow, semen, and sloughed skin, nails, and hair, although quantitatively these other routes of zinc loss are relatively small compared with gastrointestinal excretion [5] . As with intestinal excretion, the urinary elimination of zinc can be affected by zinc status [6] , although this effect is less consistent and may only occur with more severe or prolonged dietary restriction. Fecal zinc excretion is also increased during diarrhea [7] , which may contribute to zinc deficiency in areas with high rates of enteric infections.
The total body zinc content of adult humans ranges from about 1.5 to 2.5 g, most of which is found intracellularly, primarily in muscle, bone, liver, and other organs [4] . Approximately 90% of the body's zinc reserves turn over slowly and are therefore not readily available for metabolism. The remaining zinc comprises the so-called rapidly exchangeable pool of zinc, which is thought to be particularly important for maintaining zinc-dependent functions of human biological systems. The rapidly exchangeable zinc can move into and out of the plasma compartment within a period of about three days. The size of this pool is sensitive to the amounts of zinc absorbed from the diet, and a reasonably constant dietary supply is thought to be necessary to satisfy the normal requirements of zinc for maintenance and growth.
Less than 0.2% of the total body zinc content circulates in plasma, which has a mean concentration of approximately 15 µmol/L (about 100 µg/dl). Zinc is transported in plasma bound to albumin and, to a lesser extent, α 2 -macroglobulin and oligopeptides [1] . Because the concentration of zinc in tissues, such as muscle and liver, is approximately 50 times greater than that in plasma, small differences in uptake or release of zinc from these peripheral sites can have a profound effect on the plasma zinc concentration. For these reasons, plasma zinc concentrations do not indicate total body zinc stores reliably under all circumstances in individual subjects. For example, release of zinc from muscle tissue that is catabolized during starvation can result in transient, seemingly paradoxical, elevations in plasma zinc [8] . In contrast, consumption of standard meals, or glucose alone, induces a postprandial reduction in plasma zinc concentration, even though dietary zinc intake and tissue reserves may be adequate [9] . Other factors that influence plasma zinc concentration are hypoalbuminemia, which influences absorption and transport of zinc [10] ; intestinal diseases that interfere with zinc absorption [11] ; pregnancy [12] ; infection [13] [14] [15] ; and other forms of stress, such as tissue injury imposed by surgery [16] and strenuous physical exercise [17] .
Zinc and human function
Since the early reports of human zinc deficiency, and particularly during the past 10 to 15 years, a considerable number of well-designed clinical trials have been completed to examine the relationships between zinc supplementation and human health. Zinc is especially important during periods of rapid growth, both preand postnatally, and for tissues with rapid cellular differentiation and turnover, such as the immune system and the gastrointestinal tract. Critical functions that are affected by zinc nutriture include pregnancy outcome, physical growth, susceptibility to infection, and neurobehavioral development, among others.
Pregnancy outcome
Reproductive functions that have been examined in relation to zinc status are the duration of pregnancy (including rates of spontaneous abortion); fetal growth; the timing, sequencing, and efficiency of labor and delivery; and the incidence of stillbirths and congenital malformations. This voluminous literature has been reviewed by several authors [18] [19] [20] [21] [22] [23] [24] [25] . Although there are clear relationships between induced zinc deficiency and detrimental outcomes for each of these aspects of reproductive function in animal models [19, 21] , especially when zinc deficiency is severe, the results of human studies have been less consistent, possibly due to small sample sizes, other inadequacies in study design, and the difficulty of accurately classifying individual zinc status. In some cases, zinc intervention trials were conducted in unselected women who were unlikely to be zinc deficient [26, 27] , so negative results of these trials are not surprising. In almost all of the human trials, supplementation began no earlier than the second trimester of pregnancy, so there is very little information from humans on the effect of zinc nutriture during early pregnancy on pregnancy outcome.
In summary, there is considerable information from studies of animals with severe zinc deficiency and suggestive evidence from human observational studies and intervention trials to indicate that maternal zinc nutriture can influence several aspects of reproductive function and pregnancy outcome. Additional studies are needed of humans in different settings and under varied study conditions to define more precisely which women are likely to benefit from interventions to enhance their zinc status. Because of evidence from animal studies indicating that even a few days of low zinc intake at different stages of pregnancy can affect the outcome of pregnancy, human studies are needed in which supplemental zinc is provided throughout pregnancy, including the periconceptual period.
Morbidity
Research in zinc-deficient experimental animals has demonstrated dramatic changes in several components of the immune system, including lymphopenia, thymic atrophy, impaired cell-mediated immunity, and reduced antibody production. This body of work has been reviewed by Gershwin et al. [28] , Shankar and Prasad [29] , and Fraker et al. [30] , among others. Considering the likely impact of these zinc-related abnormalities of immune function, a number of studies have been completed during the past few years to determine the effects of zinc supplementation on the incidence, and in some cases the severity and duration, of diarrhea, pneumonia, and malaria. To examine the consistency of results and to increase the statistical power of the individual studies, the results of the trials examining diarrhea and pneumonia outcomes have been pooled in several secondary analyses. The results of one pooled analysis indicate that continuous zinc supplementation produces substantial and consistent reductions in both diarrhea and acute lower respiratory infections [31] . In a separate set of pooled analyses, the effect of supplementary zinc supplied as an adjunct to other therapy was evaluated in children with acute or persistent diarrhea [32] . This analysis found that zinc supplements provided as adjunctive treatment of children with either acute or persistent diarrhea reduced the duration of illness and the risk of treatment failure. Because of the known negative association between diarrheal prevalence and growth velocity, it is conceivable that zinc therapy might also reduce the impact of these illnesses on growth. Limited information is also available on the effects of zinc supplementation on the risk of malaria. In two community-based trials, zinc-supplemented children made fewer clinic visits for malaria-attributable febrile episodes [33, 34] .
Physical growth
The impact of zinc on growth was first described in humans in adolescent populations in Iran and Egypt [35, 36] . In these studies of young adults who presented with a syndrome characterized by varying degrees of growth stunting and delayed sexual maturation (hypogonadal dwarfism), treatment with zinc induced accelerated growth and commencement of sexual maturation in most participants [36, 37] . However, this response was not duplicated in a population of stunted and sexually delayed adolescents in a different area of Egypt [38] , possibly because of other limiting nutrients in their diets.
In younger children, a total of 25 controlled clinical trials of the effect of zinc supplementation on growth were summarized in a recently completed meta-anal-ysis [39] . Overall, there was a small, but highly significant, impact of zinc supplementation on children's height increments, with an average effect size of 0.22 SD. This effect was present for the subgroup of studies with mean initial height-for-age Z scores less than -2.0, but not for those with mean initial height-forage Z scores greater than or equal to -2.0. The height response to zinc supplementation was unrelated to the dosage schedule employed and the duration of supplementation. Among studies with initially stunted children, the average effect size of zinc supplementation was moderately large, averaging 0.49 SD units. There was also a small, but highly significant, impact of zinc supplementation on children's weight increments, with an average effect size of 0.26 SD units. Interestingly, the effect of zinc supplementation on change in weight was negatively associated with mean initial plasma zinc levels. Among the subset of studies with low mean initial plasma zinc concentrations (< 80 µg/dl), the impact of zinc supplementation was moderately large. The effect of zinc supplementation on children's growth may be due to its direct impact on nucleic acid and protein synthesis [40] and hormonal mediators of growth [41] , or its effects on appetite [42] or risk of infection, as discussed above [31] . On the basis of this extensive research experience, there seems to be strong evidence of a relationship between zinc deficiency and growth stunting. In those settings with high rates of stunting, underweight, low plasma zinc concentrations, or a combination of these factors, programs to enhance zinc status may be useful interventions to increase children's growth and decrease current rates of nutritional stunting.
Neurobehavioral development
As recently reviewed by Black [43] and Sandstead et al. [44] , the results of multiple studies in experimental animals indicate that a broad range of neurobehavioral abnormalities can occur with zinc deficiency. For example, fetuses of zinc-deprived pregnant rats had neuronal degeneration and a reduction in brain size [45, 46] , and the problem-solving ability of zincdepleted adult rats was less than that of control animals [47] . Studies in prepubertal monkeys with moderate zinc restriction found lower spontaneous motor activity and reduced performance of tasks that required visual attention [48] [49] [50] .
The results of studies of zinc deficiency or zinc supplementation in humans are less consistent, possibly due in part to the broad range of subjects observed and the research designs employed. Nevertheless, a number of zinc-related behavioral abnormalities have also been described in humans. These include reports of changes in mood, loss of affect and emotional lability, anorexia, dysfunction of smell and taste, irritability, and depres-sion [51, 52] . In trials in young children and pregnant women, zinc supplementation resulted in increased motor development scores [53] and increased activity and/or responsiveness in young children or fetuses [54] [55] [56] [57] , including a significantly reduced need for assisted ventilation of newborns in one study [58] . Researchers generally agree that the mechanisms by which zinc deprivation induces behavioral changes are unclear, and further study is needed to determine at what stage zinc deficiency influences behavior, whether these effects are reversible, how long zinc supplementation is needed to prevent the risks, and whether zinc must be provided along with other limiting nutrients to be effective.
Dietary sources and bioavailability of zinc
In addition to the previously described effect of an individual's zinc status on zinc absorption, the total zinc content of the diet and the bioavailability of zinc from its food components also influence the efficiency of zinc absorption. Discounting the effect of zinc status, zinc absorption is determined largely by its solubility in the intestinal lumen, which in turn is affected by the chemical form of zinc and the presence of specific inhibitors and enhancers of absorption. The major inhibitor of zinc absorption is myoinositol hexaphosphate (phytate), which is present in many plant foods, especially cereals and legumes, and irreversibly binds zinc under conditions present in the intestinal lumen. Organs and flesh of mammals, fowl, fish, and crustaceans are the richest food sources of zinc, and these foods do not contain phytate; therefore, they are particularly good sources of absorbable zinc (table 1) . Eggs and dairy products are also free of phytate, although they have a slightly lower zinc content than organs and flesh foods. Most cereals and legumes have an intermediate level of zinc, but their high phytate content reduces the amount of zinc available for absorption. When these staples are fermented (as occurs with leavened breads and with porridges prepared from fermented cereals), the fermenting organisms produce phytases that break down phytates, thus increasing the amount of absorbable zinc. Rice and starchy roots and tubers have lower zinc contents than legumes and cereals other than rice. For the most part, fruits and vegetables are not rich sources of zinc, although some green leafy vegetables, like spinach, have a fairly high zinc density, albeit of uncertain bioavailability.
To estimate the likely absorption of zinc from the mixed diet, a phytate-zinc molar ratio can be calculated as the phytate content of the foods/660 (the molecular weight (MW) of phytate) divided by the zinc content of the foods/65.4 (the molecular weight [62] [63] [64] . It is generally considered that diets with a phytate-zinc molar ratio greater than 15 have relatively poor zinc bioavailability, those with a phytate-zinc molar ratio between 5 and 15 have medium zinc bioavailability, and those with a phytate-zinc molar ratio less than 5 have relatively good zinc bioavailability [65] . The relationship between zinc intake, the phytate-zinc molar ratio of the diet, and zinc absorption has been described by the World Health Organization (WHO) [65] , which defined three categories of diets with high, medium, or low zinc availability, based on the proportion of energy from animal sources, the types of processing of cereals, the amounts of inorganic calcium salts, and the zinc:phytate molar ratio. WHO [65] estimates that about 45% to 55% of the element is absorbed from a high-bioavailability diet, 30% to 35% from a medium-bioavailability diet, and 10% to 15% from a low-bioavailability diet ( fig. 1 ), depending on the zinc content of the meal and assuming a typical intake of approximately 3 to 5 mg per meal.
Based on her own and others' research, Sandström has recently summarized studies of the fractional and net absorption of zinc under different dietary conditions [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] . Zinc was absorbed most efficiently from aqueous solutions and from meals containing animal products. Absorption was considerably less from phytate-containing meals. Fortification of foods with exogenous zinc generally produced a small reduction in fractional absorption but had a positive impact on net absorption. However, fortification of foods with a high phytate:zinc molar ratio had only a small effect on net zinc absorption. Another approach to increasing the amount of zinc absorbable from highphytate foods is to reduce the phytate content of these foods. Gibson et al. [78] reviewed the use of different food-processing methods, such as milling, soaking, and fermentation, to increase the bioavailability of zinc and other minerals, such as iron and calcium, from high-phytate staple foods. Specific practices that are compatible with local experience could be encouraged as an alternative or adjunct to other methods of increasing the availability of zinc. Because of remaining uncertainties in the estimates of zinc absorption from different diets by individuals of different zinc status, further work is needed to validate the ability of dietary data to predict zinc status.
Zinc requirements

Determining adequacy of zinc
Estimates of zinc requirements have been developed by several expert committees, including those convened by WHO [65] , the National Research Council of the United States [79] , and the Panel on Dietary Reference Values of the United Kingdom [80] . The WHO committee estimated the physiological zinc requirements of adults as the sum of the amounts needed for tissue growth, maintenance, metabolism, and replacement of endogenous losses. Because intestinal and urinary losses change in relation to zinc status, two separate estimates of these requirements were developed. The so-called basal requirements of 1.0 mg/day in adult males and 0.7 mg/day in adult females refer to the amounts needed to balance the aforementioned physiological requirements of individuals who are fully adapted to low zinc intakes. Because this level of intake leaves no reserve for adaptation to any further decrease in intake, the second estimate was developed to provide a greater margin of safety. This estimate, which is referred to as the "normative physiological requirement," accounts for the fact that zinc absorption must be about 40% greater to balance fecal and urinary losses in individuals who are not yet adapted to low intakes. Hence, the normative zinc requirement was set at 1.4 mg/day for adult men and 1.0 mg/day for adult women.
Once the normative zinc requirement is applied to a particular category of individuals, the dietary requirement must be adjusted to account for the estimated percentage of zinc absorption from the diet (dietary requirement = normative requirement/ % absorption from usual diet). The WHO committee further suggested that population dietary recommendations should be established at a level such that individuals who consume 2 SD less than the population average intake would be able to satisfy their [65] normative requirement. This would assure that in populations with a mean intake at the recommended population level, nearly all individuals would be able to satisfy their zinc needs. The WHO committee assumed a coefficient of variation in dietary intake of 25% and therefore proposed that the population mean "normative dietary requirement" should be set at a level such that 50% (or 2 SD) less than this mean would be equivalent to the age-and sex-specific normative requirement. For example, if the normative requirement for adult men is 1.4 mg/day and the diet is of medium bioavailability (i.e., there is approximately 30% zinc absorption), then the normative dietary requirement is 1.4/0.3 = 4.7. The population mean dietary requirement is therefore set at 9.4 mg/day to assure that individuals who consume only 50% of the population mean dietary requirement would satisfy their normative dietary requirement.
In addition to the foregoing reasoning applied to adults, the estimates of zinc requirements for children take into consideration the amounts needed for accretion of newly formed tissue and the proportionately greater endogenous losses of zinc per unit body weight that occurs in children. To account for the latter phenomenon, the endogenous losses per unit of basal metabolic rate in adults (rather than per unit body weight) were applied to children. The population mean dietary requirements suggested by WHO are presented by age, sex, and physiological status in table 2. It should be noted that the WHO recommendations assume that a fully breastfed infant under six months of age is able to meet his or her zinc needs from breastmilk alone.
The US National Research Council similarly assumed that zinc requirements of adults could be established by measuring endogenous losses and adjusting this for the amount of zinc absorbed from the diet. However, the US recommendations considered only one level of zinc absorption from a mixed diet (20% of intake). The US recommendations are generally consistent with the WHO recommendations for a diet with low to medium zinc bioavailability. The UK recommendations applied a similar conceptual framework but assumed a single figure of 30% absorption from the diet. Hence, the estimated UK reference zinc intake is generally less than the US estimate and is consistent with the WHO estimate for a medium bioavailability diet.
Zinc toxicity
Zinc has a low toxicity, although acute symptoms of nausea, vomiting, diarrhea, fever, and lethargy may be observed when large (about 1 g) doses are consumed. When zinc intake exceeds physiological needs by reasonably small amounts, homeostasis can be maintained by increased endogenous fecal and urinary excretion. However, if excessive zinc intake continues for prolonged periods of time, absorption of other trace elements, especially copper and iron, can be impaired. For example, intakes of supplements providing 50 mg of zinc per day for six weeks produced changes in erythrocyte copper-zinc superoxide dismutase, an indicator of copper status [81, 82] . At higher doses of zinc (160-660 mg/day), anemia and changes in immune function and lipoprotein metabolism have been observed in addition to abnormal indices of copper status [83] [84] [85] [86] . Further studies are needed to specify the level of zinc intake at which any undesirable effects on copper metabolism, hematologic indices, immune function, and lipoprotein metabolism begin to occur. Moreover, it needs to be determined whether the recommended upper limit of zinc intake should be modified when it is consumed with other foods of varied phytate content. There is also some evidence that adverse effects of zinc are more likely to occur when copper intakes are low, and a zinc:copper molar ratio of no more than 15 has been suggested [87, 88] . 
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Assessment of zinc status
Several authors have reviewed the range of techniques that have been proposed for evaluating the zinc nutriture of individuals and populations [89] [90] [91] . Most researchers agree that efficient regulation of zinc homeostasis complicates the diagnosis of zinc deficiency and excess. There are no generally accepted, reliable biomarkers of individual zinc status. Only when zinc deficiency is relatively severe is it possible to detect changes in tissue zinc concentrations. For these reasons, the definitive diagnosis of zinc deficiency is usually based on a high index of suspicion (as motivated by low dietary intake and/or poor bioavailability of zinc and/or suggestive clinical signs, such as growth retardation, delayed sexual maturation, dermatitis, behavioral changes, and defects in immune function) and documentation of a functional response to zinc supplementation. Obviously, the need to conduct a therapeutic trial to identify a functional response to supplementation complicates the ability to diagnose zinc deficiency and increases the cost of this assessment, especially because several months may be needed to measure certain functional responses, such as physical growth, with confidence.
Of the alternative techniques that have been proposed for direct evaluation of a population's zinc status, the ones that seem most promising for field application are assessment of the adequacy of zinc intakes and measurement of the population's mean plasma zinc concentration.
Assessment of zinc status using plasma zinc
Use of the mean plasma zinc concentration to assess the zinc status of a population requires proper collection and processing of blood from a representative sample of the population and analysis of the zinc concentration in the plasma or serum. Despite the difficulties in interpreting the plasma zinc concentration of individual subjects, there are several pieces of evidence that suggest that the mean plasma zinc concentration of a group of individuals may provide useful information on the zinc status of the population from which that sample is derived. For example, when the zinc intake of groups of volunteer study subjects is severely restricted, the mean plasma zinc concentration diminishes within a fairly short period of time [6] , although the decline in plasma zinc concentration is more subtle when zinc intake is only moderately restricted [17] . Nevertheless, results from a recent meta-analysis of zinc intervention trials indicate that the mean plasma zinc concentration of subjects in individual studies predicted the magnitude of the response in weight gain following zinc supplementation [39] . When the initial mean plasma zinc concentration was greater than about 80 µg/dl, there was no response to zinc supplementation. With decreasing plasma zinc concentrations, there was, in general, a progressively greater response to zinc. Moreover, almost all studies found a significant increase in the plasma zinc concentrations following supplementation, suggesting that this indicator could also be used to assess successful delivery of zinc supplements.
Assessment of zinc status using dietary intake data
Gibson and Ferguson [92] have prepared a manual describing a field-applicable method for determining the adequacy of dietary zinc (and iron) intakes in developing countries. Dietary assessment requires quantitative measurement of food intake from a representative sample of the population of interest, knowledge of the zinc content of these foods, and appraisal of the likely absorption of zinc from the mixed diets [93, 94] . Dietary intake can be assessed quantitatively by a number of different methods, the simplest of which for population assessment is a modified interactive 24-hour dietary recall [92, 94, 95] . Once the daily food intake is known, the total zinc intakes can be estimated by multiplying the amounts of each of the foods that are consumed by their zinc contents, as recorded in local food-composition tables or in databases available internationally, such as the US Department of Agriculture (USDA) food-composition database [61] . In developing countries, the World Food Dietary Assessment System can be used [59] . The nutrient database associated with this system contains food composition values for 1800 foods from six countries (Egypt, Kenya, Mexico, Senegal, India, and Indonesia) and provides data for 53 nutrients and antinutritional factors, including zinc, iron, dietary fiber, and phytate. Local databases are theoretically advantageous because the zinc content of foods can vary according to soil conditions, agronomic practices, and local food processing-techniques, although in many cases local food-composition tables contain fewer food items and fewer replicate analyses per item. Moreover, these local tables frequently omit analyses of zinc and/or phytic acid. To estimate the amount of zinc available for absorption from the diet, the diet can be categorized according to its phytate:zinc molar ratio, as described above.
Estimates of the global prevalence of zinc defi ciency
Several authors have presented cogent arguments that zinc deficiency is likely to be widespread in low-income countries [96] [97] [98] . However, quantitative estimates of the percentage of the global population at risk of inadequate zinc nutriture and specific information on the prevalence of deficiency in particular settings are still lacking, in large part because of the aforementioned difficulties in assessing individual zinc status. This lack of information has been a major limiting factor in convincing policy makers of the need to develop programs to reduce the rate of zinc deficiency.
One indirect method that can be used for estimating global rates of zinc deficiency is analysis of previously collected information on the total daily per capita amount of zinc in the national food supply in relation to the population's theoretical zinc requirements, and a second indirect indicator to consider is a review of national rates of childhood stunting, as documented in the UNICEF report of the State of the World's Children [99] . These are described in the following paragraphs.
Zinc in the global food supply
Data on the amounts of major food commodities available for human consumption are listed for most countries in the food-balance sheets of the Food and Agriculture Organization (FAO) [60] . Despite the inherent weaknesses in this type of national-level statistics, the food-balance sheets provide reasonably reliable information on the total amounts and types of foods available in a broad range of countries. By calculating the amount of zinc present in these foods and the amounts that are potentially absorbable, as estimated from their phytate:zinc ratios, it is possible to assess whether the food supply is adequate to satisfy the population's theoretical requirements for zinc.
To estimate the zinc content of the global food supply, information was downloaded from the FAO food-balance sheets [60] . The food-balance sheets provide information on the annual amounts of 95 major food commodities that are available for human consumption in 178 different countries. The amount of zinc potentially available for absorption from these foods was also estimated by using WHO guidelines based on the phytate:zinc ratio (P:Z) of the food supply [65] . Table 3 displays regional data on the mean daily per capita availability of the following items in the food supply of 178 countries: total energy (kcal/day), total zinc (mg/day), zinc density (mg/1000 kcal), phytate (mg/day), P:Z molar ratio, estimated absorbable zinc (mg/day), and zinc as a percentage of the weighted average daily per capita zinc requirement. The regions are ranked in descending order according to the amount of absorbable zinc in the food supply. The mean daily per capita amount of zinc in the national food supply ranges from about 11 to 12 mg/day in the more affluent countries of Western Europe, North America, and the Western Pacific, to about 7 to 9 mg/day in the poorer regions of South and Southeast Asia, Northern Africa and Eastern Mediterranean, and sub-Saharan Africa. The zinc content of the national food supplies in China and Latin America is intermediate. The total zinc content of national food supplies is strongly associated with the total energy content the and percentage of energy provided by animal sources (data not shown). Notably, in the wealthier countries, more than half the zinc is provided by animal sources, as compared with 15% to 25% in the poorer countries, leading to sizable differences in the P:Z molar ratios among regions and approximately threefold differences in the estimated amount of zinc that is likely to be absorbed from the available foods (table 3) . The food supply of Western Europe and North America provides about 150% of the weighted mean per capita normative population dietary requirement, whereas the food supply of South and Southeast Asia, Northern Africa and Eastern Mediterranean, and sub-Saharan Africa provides only about 50% to 60% of this requirement.
The percentage of the population at risk for inadequate intake was estimated for each country, as follows. The mean normative dietary requirement of zinc was assumed to be 50% of the WHO population dietary requirement, as calculated above, and was assumed to be fixed. The availability of food sources of zinc to individuals was assumed to follow a Gaussian distribution, with the standard deviation equal to 25% of the mean, as suggested by WHO [65] . The percentage of the population at risk was therefore calculated as the area under the normal curve to the left of the normative physiological requirement. According to this approach, the global food supply places nearly half the world's population at risk of low zinc intake (i.e., the national food supplies of the countries analyzed provide nearly half the people in the world with less than the weighted mean per capita normative dietary requirement of their respective countries). The percentage of the national population at risk for low zinc intake ranges from 1%-13% in countries of Europe and North America to 68%-95% in South and Southeast Asia, Africa, and the Eastern Mediterranean regions, and globally nearly half of the world's population is at risk for low zinc intake.
A number of weaknesses in this approach to estimating the global prevalence of zinc deficiency must be recognized. First, the estimates of the amount of zinc in the food supply are only as good as the information provided in the national food-balance sheets. Because the amount of zinc in national food supplies is strongly correlated with the total amount of food energy, any underestimates in the available food supply will result in overestimates of the number of individuals at risk of low intake, and vice versa. Second, the food-balance sheets provide national-level data, and no information is given on the distribution of the food supply among and within households. Although an assumption of a 25% coefficient of variation in population zinc intake was employed, as suggested by WHO, if the actual variability in intake is greater than this, the current analyses would tend to underestimate the percentage of individuals at risk for low intake in countries with food zinc supplies above the requirement and overestimate the percentage of individuals at risk for low intake in countries with food zinc supplies below the requirement.
Third, the WHO estimates of age-and sex-specific normative physiological requirements assume that these are fixed, when in fact they vary among individuals. It is conceivable that some individuals might satisfy their physiological needs with lower zinc intakes. Finally, other possible flaws in this approach can result from inaccuracies in the food-composition database, failure to correct adequately for the effects of food processing on zinc and phytate contents, and uncertainties in the estimated physiological requirements for zinc and bioavailability of zinc from different diets. Also, it must be recognized that the total amount of food in the national food supply is almost certainly greater than the amounts actually consumed, and this difference between food availability and food consumption is probably greater in the more affluent countries. Notwithstanding the uncertainties in the estimates of the adequacy of zinc in national food supplies, the data do provide reasonable insights into the countries and regions that are likely to be at greatest risk for low intakes of absorbable zinc and consequent zinc deficiency.
Stunting
As mentioned, children with moderate to severe stunting respond to zinc supplementation more than children who are not stunted. Notably, those countries with high rates of stunting tend to be those with high risks of low zinc intake due to low availability of zinc in the food supply. Those countries also tend to have elevated rates of infant and child mortality, low birthweight, and postnatal malnutrition [99] . These relationships do not indicate causality, but they do suggest that high rates of stunting could be included as a possible indicator of zinc deficiency in the absence of more reliable indicators of zinc status.
Conclusions
Although there are no generally accepted biomarkers of zinc status, it is possible to use plasma zinc or consumption of dietary zinc (while considering the bioavailability of that zinc) in representative samples of the population as two relatively reliable methods of assessing zinc deficiency in those populations. However, these data are only available in a few countries throughout the world. National food-balance sheets are available from at least 178 countries, and the rates of stunting in children under five years of age are available in at least 163 countries worldwide. Therefore, these could be used as preliminary indica-tors of the risk of zinc deficiency until more appropriate data are available. Based on the information presented above concerning the amount of zinc present in national food supplies, it appears that the risk of low dietary intake of absorbable zinc and consequent zinc deficiency are widespread problems affecting between one-third and one-half of the world's population. Zinc deficiency may induce a number of critical functional abnormalities, including impaired reproductive performance, depressed immune function and secondary increases in the incidence and severity of infections, growth failure and secondary nutritional stunting, and abnormalities of neurobehavioral development. Because of the likely high global prevalence of zinc deficiency and the serious range of complications that can be induced by this condition, public health programs are urgently needed to prevent low zinc intake and poor absorption of zinc.
